Brief: Nanobiotix Publishes New Clinical Case Study For Pancreatic Cancer Treatment

Nanobiotix SA

10/02/2022 08:50

Feb 10 (Reuters) - Nanobiotix SA  NANOB.PA :
    * NANOBIOTIX ANNOUNCED ON WEDNESDAY THE PUBLICATION OF NEW
CLINICAL CASE STUDY HIGHLIGHTING FIRST PATIENT EXPERIENCE OF
NBTXR3 TREATMENT FOR PANCREATIC CANCER
    * REPORT CONCLUDED THAT THE TREATMENT WAS FEASIBLE
    * NANOBIOTIX EXPECTS TO ESTABLISH THE RECOMMENDED PHASE II
DOSE
FOR NBTXR3 IN PANCREATIC CANCER IN 2022

Source text for Eikon:  ID:nBw1tyjmHa 
Further company coverage:  NANOB.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))